Key result
Prior CABG predicts a ~14-fold higher TLR risk after EES implantation.
Why the study?
The clinical and angiographic outcomes after PCI with everolimus-eluting stent implantation in patients with a history of coronary artery bypass grafting have yet to be fully investigated.
Does a history of CABG increase the risk of adverse clinical outcomes in patients undergoing everolimus-eluting stent implantation?
Cohort (n=176)
No
Does a history of CABG increase the risk of adverse clinical outcomes in patients undergoing everolimus-eluting stent implantation?
Answers are grounded in this paper and cite their sources.
A history of CABG is a significant risk factor for target lesion revascularization and major adverse cardiac events after everolimus-eluting stent implantation, highlighting the poor outcomes of PCI in this high-risk subset.
The clinical and angiographic outcomes after percutaneous coronary intervention (PCI) with everolimus-eluting stent (EES) implantation in patients with a history of coronary artery bypass grafting (CABG) have yet to be fully investigated. The aim of the present study was to investigate 3-year clinical outcomes after EES implantation in patients with a history of CABG.We retrospectively enrolled 176 consecutive patients who had undergone EES implantation. Three-year clinical follow-up data were obtained from all patients. Follow-up angiograms and serial quantitative coronary angiography analysis (QCA) were performed for 139 (79.0%) patients. Patients from the prior CABG (+) group (n = 17; 9.7%) had higher incidences of target lesion revascularization (TLR; 41.2% versus 3.8%, P < 0.001) and major adverse cardiac events (47.1% versus 15.1%, P = 0.004). A landmark analysis conducted 1 year into our study showed a higher incidence of TLR in the prior CABG (+) group (20.0% versus 3.0%, P = 0.017).The reason for EES implantation in the prior CABG (+) group was saphenous vein graft (SVG) failure in 19 (79.2%) lesions, although the target vessel was the SVG in 8 (33.3%) lesions. There were no significant differences in clinical and follow-up QCA data between the native vessel and SVG PCI groups.This study revealed that a history of CABG was a risk factor for TLR after EES implantation. The major reason for PCI after CABG was SVG failure; both native vessel and SVG PCI showed poor outcomes. Further investigations may be warranted to determine which interventions are most effective in this high-risk subset.
No takes yet. Share an insight, caveat, or question.
Nomura et al. (2016) conducted a cohort in Coronary artery disease requiring percutaneous coronary intervention (n=176). History of coronary artery bypass grafting (CABG) vs. No history of coronary artery bypass grafting was evaluated on Target lesion revascularization (TLR) (HR 13.62, 95% CI 4.08-45.44, p=<0.001). A history of coronary artery bypass grafting was a strong independent predictor of target lesion revascularization after everolimus-eluting stent implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: